Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study. ccm [Internet]. 2023 Dec. 5 [cited 2026 Sep. 17];7(6):349-54. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16439